Daniil Gataulin
Stock Analyst at Chardan Capital
(1.66)
# 3,006
Out of 4,829 analysts
89
Total ratings
22.78%
Success rate
-8.94%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniil Gataulin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRVO CervoMed | Maintains: Buy | $14 → $15 | $9.10 | +64.84% | 6 | May 12, 2025 | |
| OCGN Ocugen | Maintains: Buy | $7 | $0.70 | +900.00% | 11 | May 12, 2025 | |
| QURE uniQure | Maintains: Buy | $38 | $13.15 | +188.97% | 3 | May 12, 2025 | |
| OCS Oculis Holding AG | Maintains: Buy | $28 → $33 | $17.60 | +87.50% | 7 | May 9, 2025 | |
| EYPT EyePoint Pharmaceuticals | Maintains: Buy | $33 → $27 | $5.85 | +361.54% | 11 | May 8, 2025 | |
| CGTX Cognition Therapeutics | Maintains: Buy | $8 → $4 | $0.33 | +1,123.62% | 7 | May 8, 2025 | |
| TRML Tourmaline Bio | Maintains: Buy | $70 | $15.80 | +343.04% | 2 | May 5, 2025 | |
| UBX Unity Biotechnology | Maintains: Buy | $4 | $0.91 | +339.61% | 4 | Apr 23, 2025 | |
| ADVM Adverum Biotechnologies | Maintains: Buy | $40 → $33 | $2.71 | +1,117.71% | 6 | Apr 17, 2025 | |
| FBRX Forte Biosciences | Maintains: Buy | $64 → $61 | $6.30 | +868.25% | 4 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 | $0.89 | +573.78% | 4 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 | $7.97 | +552.45% | 10 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 | $5.62 | +540.57% | 3 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3 | $1.59 | +88.68% | 8 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $220 | $2.25 | +9,677.78% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.14 | - | 2 | Jul 25, 2023 |
CervoMed
May 12, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $9.10
Upside: +64.84%
Ocugen
May 12, 2025
Maintains: Buy
Price Target: $7
Current: $0.70
Upside: +900.00%
uniQure
May 12, 2025
Maintains: Buy
Price Target: $38
Current: $13.15
Upside: +188.97%
Oculis Holding AG
May 9, 2025
Maintains: Buy
Price Target: $28 → $33
Current: $17.60
Upside: +87.50%
EyePoint Pharmaceuticals
May 8, 2025
Maintains: Buy
Price Target: $33 → $27
Current: $5.85
Upside: +361.54%
Cognition Therapeutics
May 8, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $0.33
Upside: +1,123.62%
Tourmaline Bio
May 5, 2025
Maintains: Buy
Price Target: $70
Current: $15.80
Upside: +343.04%
Unity Biotechnology
Apr 23, 2025
Maintains: Buy
Price Target: $4
Current: $0.91
Upside: +339.61%
Adverum Biotechnologies
Apr 17, 2025
Maintains: Buy
Price Target: $40 → $33
Current: $2.71
Upside: +1,117.71%
Forte Biosciences
Apr 1, 2025
Maintains: Buy
Price Target: $64 → $61
Current: $6.30
Upside: +868.25%
Mar 28, 2025
Maintains: Buy
Price Target: $6
Current: $0.89
Upside: +573.78%
Mar 20, 2025
Maintains: Buy
Price Target: $52
Current: $7.97
Upside: +552.45%
Feb 24, 2025
Maintains: Buy
Price Target: $36
Current: $5.62
Upside: +540.57%
Feb 18, 2025
Maintains: Neutral
Price Target: $3
Current: $1.59
Upside: +88.68%
Mar 7, 2024
Maintains: Buy
Price Target: $220
Current: $2.25
Upside: +9,677.78%
Jul 25, 2023
Downgrades: Neutral
Price Target: n/a
Current: $4.14
Upside: -